Follow
Brett King
Brett King
Unknown affiliation
No verified email - Homepage
Title
Cited by
Cited by
Year
Ultra-fast excited state dynamics in green fluorescent protein: multiple states and proton transfer.
M Chattoraj, BA King, GU Bublitz, SG Boxer
Proceedings of the National Academy of Sciences 93 (16), 8362-8367, 1996
10591996
JAK inhibitors in dermatology: the promise of a new drug class
W Damsky, BA King
Journal of the American Academy of Dermatology 76 (4), 736-744, 2017
5512017
Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials
EL Simpson, JP Lacour, L Spelman, R Galimberti, LF Eichenfield, ...
British Journal of Dermatology 183 (2), 242-255, 2020
4442020
Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
MK Crispin, JM Ko, BG Craiglow, S Li, G Shankar, JR Urban, JC Chen, ...
JCI insight 1 (15), 2016
3742016
Tofacitinib for the treatment of severe alopecia areata and variants: a study of 90 patients
LY Liu, BG Craiglow, F Dai, BA King
Journal of the American Academy of Dermatology 76 (1), 22-28, 2017
3642017
Two phase 3 trials of baricitinib for alopecia areata
B King, M Ohyama, O Kwon, A Zlotogorski, J Ko, NA Mesinkovska, ...
New England Journal of Medicine 386 (18), 1687-1699, 2022
3432022
Tofacitinib citrate for the treatment of vitiligo: a pathogenesis-directed therapy
BG Craiglow, BA King
JAMA dermatology 151 (10), 1110-1112, 2015
3332015
A neutrophil activation signature predicts critical illness and mortality in COVID-19
ML Meizlish, AB Pine, JD Bishai, G Goshua, ER Nadelmann, M Simonov, ...
Blood advances 5 (5), 1164-1177, 2021
3162021
Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis
BG Craiglow, BA King
J invest dermatol 134 (12), 2988-2990, 2014
2752014
Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate
LL Levy, J Urban, BA King
Journal of the American Academy of Dermatology 73 (3), 395-399, 2015
2672015
Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure
LY Liu, JP Strassner, MA Refat, JE Harris, BA King
Journal of the American Academy of Dermatology 77 (4), 675-682. e1, 2017
2392017
Crystal structure and photodynamic behavior of the blue emission variant Y66H/Y145F of green fluorescent protein
RM Wachter, BA King, R Heim, K Kallio, RY Tsien, SG Boxer, ...
Biochemistry 36 (32), 9759-9765, 1997
2301997
Tofacitinib for the treatment of alopecia areata and variants in adolescents
BG Craiglow, LY Liu, BA King
Journal of the American Academy of Dermatology 76 (1), 29-32, 2017
2022017
Health-related quality of life (HRQoL) among patients with alopecia areata (AA): a systematic review
LY Liu, BA King, BG Craiglow
Journal of the American Academy of Dermatology 75 (4), 806-812. e3, 2016
1922016
The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata
N Meah, D Wall, K York, B Bhoyrul, L Bokhari, DA Sigall, WF Bergfeld, ...
Journal of the American Academy of Dermatology 83 (1), 123-130, 2020
1852020
Dupilumab as a novel therapy for bullous pemphigoid: a multicenter case series
R Abdat, RA Waldman, V de Bedout, A Czernik, M Mcleod, B King, ...
Journal of the American Academy of Dermatology 83 (1), 46-52, 2020
1782020
Tofacitinib treatment and molecular analysis of cutaneous sarcoidosis
W Damsky, D Thakral, N Emeagwali, A Galan, B King
New England Journal of Medicine 379 (26), 2540-2546, 2018
1632018
A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24 …
B King, E Guttman-Yassky, E Peeva, A Banerjee, R Sinclair, AB Pavel, ...
Journal of the American Academy of Dermatology 85 (2), 379-387, 2021
1552021
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): the development and reliability testing of a novel clinical outcome measurement instrument for the …
E Simpson, R Bissonnette, LF Eichenfield, E Guttman-Yassky, B King, ...
Journal of the American Academy of Dermatology 83 (3), 839-846, 2020
1452020
Atypical hand-foot-and-mouth disease associated with coxsackievirus A6 infection
JP Lott, K Liu, ML Landry, WA Nix, MS Oberste, J Bolognia, B King
Journal of the American Academy of Dermatology 69 (5), 736-741, 2013
1442013
The system can't perform the operation now. Try again later.
Articles 1–20